Endo Pharmaceuticals

GVK Biosciences, Endo collaborate on novel small molecules

Monday, February 4, 2013 03:12 PM

India-based CRO GVK Biosciences has entered into a collaboration agreement with U.S.-based Endo Pharmaceuticals, focusing on discovering novel small molecules targeting an exciting protein.

More... »


Jorkasky joins Tengion’s board of directors

Tuesday, August 16, 2011 02:23 PM

Tengion has named Diane Jorkasky, M.D. to its board of directors. Jorkasky recently joined Endo Pharmaceuticals as senior vice president, clinical development and chief medical officer. She was previously chief development and medical officer at Aileron Therapeutics.

More... »


Endo to acquire American Medical Systems

Monday, April 11, 2011 12:07 PM

Endo Pharmaceuticals and American Medical Systems (AMS) have entered into a definitive agreement under which Endo will acquire AMS, a provider of devices and therapies for male and female pelvic health, for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt. The combined company will deliver comprehensive healthcare solutions across its businesses in branded pharmaceuticals, generics and devices and services, in the therapeutic areas of urology and pain.

More... »

First patient enrolled in second phase III trial of Urocidin

Tuesday, March 1, 2011 08:00 AM

Endo Pharmaceuticals and Bioniche Life Sciences have enrolled the first patient in the second phase III clinical trial of Urocidin.

More... »

MyClin offers virtual communities for sponsors, CROs, sites to stay connected during trials

Monday, November 29, 2010 09:00 AM

At the investigator meeting prior to the start of a clinical trial, principal investigators and their staffs sit together to hear the sponsor explain the protocol and to ask questions. Everyone socializes over snacks or a meal, connecting faces to names and discussing the ins and outs of the trial.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013
Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings
Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving
Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.